Lck-IN-4
Lck-IN-4 (Compound A-1) is a protein tyrosine kinase Lck inhibitor with an IC50 of 2 nM. Lck-IN-4 significantly inhibits YAP tyrosine phosphorylation and activity and induces apoptosis in cholangiocarcinoma CCA cells. Lck-IN-4 is cytotoxic in CCA tumor-derived organoids with elevated YAP activity Lck-IN-4 can be used for cancers like cholangiocarcinoma (CCA) research[1].
Product Specifications
CAS Number
1326278-38-9
UNSPSC
12352005
Target
Apoptosis; Src
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
CC1=NC=CN2C([C@H]3CC[C@H](N4CCN(CC4)C)CC3)=NC(C5=CC(OC)=C(C=C5)NC(C6=CC7=C(OC)C=CC=C7N6C)=O)=C12
Molecular Formula
C36H43N7O3
Molecular Weight
621.77
References & Citations
[1]Buijsman R C, et al. Treatment of subjects suffering from having cholangiocarcinoma. WO2023052406A1. 2023-04-06.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Mitochondrial Import Receptor Subunit TOM70 (TOMM70A) ELISA Kit
Human Mitochondrial Import Receptor Subunit TOM70 (TOMM70A) ELISA Kit
Human Mitochondrial Import Receptor Subunit TOM70 (TOMM70A) ELISA Kit
ATRN (Attractin, Attractin-2, DPPT-L, KIAA0548, Mahogany Protein, MGCA, Mahogany Homolog) discontinued